SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Mar 1, 2004
Document Date
Mar 1, 2004
Form Description
REGDEX/A
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc